Grippe aviaire et transmission chez l'homme (2006) Delvallée/Documentation

Liens utiles

17.Conseils aux voyageurs http://www.diplomatie.fr/voyageurs/etrangers/avis/conseils/default2.asp

18.FAO des Nations Unies http://www.fao.org/ag/againfo/subjects/en/health/diseases-cards/avian_update.html

19.Eurosurveillance http://www.eurosurveillance.org/index-01.asp

20.Maladies émergentes http://www.promedmail.org/pls/askus/f?p=2400:1000

Références bibliographiques

1. FAO, OIE and OMS (2005). "Lignes directrices sur la prévention et le contrôle de l'influenza aviaire." Organisation des Nations Unies pour l'alimentation et l'agriculture-Organisation Internationale des épizooties- Organisation Mondiale de la Santé.

2. OMS (2003). "Production of pilot lots of inactivated influenza vaccines from reassortants derived from avian influenza viruses. Interim biosafety risk assessment." Organisation Mondiale de la Santé.

3. OMS (2004). "Exposures that may have put a person at risk of becoming infected with influenza A(H5N1)." Organisation Mondiale de la Santé.

4. OMS (2005). "WHO guidance on development of influenza vaccine reference viruses by reverse genetics." Organisation Mondiale de la Santé.

5. OMS (2005). "Recommended laboratory tests to identify avian influenza A virus in specimens from humans." Organisation Mondiale de la Santé.

6. OMS (2006). "Cumulative Number of Confirmed Human Cases of Avian Influenza A/(H5N1) Reported to WHO." Organisation Mondiale de la Santé.

7. OMS (2006). "Avian influenza, including influenza A (H5N1), in humans : WHO interim infection control guideline for health care facilities." Organisation Mondiale de la Santé.

8. UPMC (2005). "Peramivir : Single Dose Prophylaxis for Flu?" Center for Biosecurity of UPMC, for a briefing on Capitol Hill.

9. Abed Y, Hardy I, Li Y and Boivin G (2002). "Divergent evolution of hemagglutinin and neuraminidase genes in recent influenza A:H3N2 viruses isolated in Canada." Journal of medical virology67(4) : 589-595.

10. Al Faress S, Cartet G, Ferraris O, Norder H, Valette M and Lina B (2005). "Divergent genetic evolution of hemagglutinin in influenza A H1N1 and A H1N2 subtypes isolated in the south-France since the winter of 2001-2002." J Clin Virol33(3) : 230-6.

11. Alexander DJ, Van RK and Pensaert M (2000). "A review of avian influenza in different bird species." Veterinary microbiology  : (Amsterdam)74(1-2) : 3-13.

12. Amonsin A, Payungporn S, Theamboonlers A, Thanawongnuwech R, Suradhat S, Pariyothorn N, Tantilertcharoen R, Damrongwantanapokin S, Buranathai C, Chaisingh A, Songserm T and Poovorawan Y (2005). "Genetic characterization of H5N1 influenza A viruses isolated from zoo tigers in Thailand." Virology 344(2) : 480-491.

13. Apisarnthanarak A, Erb S, Stephenson I, Katz JM, Chittaganpitch M, Sangkitporn S, Kitphati R, Thawatsupha P, Waicharoen S, Pinitchai U, Apisarnthanarak P, Fraser VJ and Mundy LM (2005). "Seroprevalence of anti-H5 antibody among Thai health care workers after exposure to Avian influenza (H5N1) in a tertiary care center." Clin Infect Dis 40(2) : e16-8.

14. Apisarnthanarak A, Kitphati R, Thongphubeth K, Patoomanunt P, Anthanont P, Auwanit W, Thawatsupha P, Chittaganpitch M, Saeng-Aroon S, Waicharoen S, Apisarnthanarak P, Storch GA, Mundy LM and Fraser VJ (2004). "Atypical avian influenza (H5N1)." Emerg Infect Dis 10(7) : 1321-4.

15. Aymard M, Gerentes L and Kessler N (1999). "Place des anticorps antineuraminidase dans la protection contre la grippe. (Role for antibody to neuraminidase in protecting against influenza)." La Semaine des hôpitaux de Paris75(23-24) : 933-941.

16. Babai I, Barenholz Y, Zakay-Rones Z, Greenbaum E, Samira S, Hayon I, Rochman M and Kedar E (2001). "A novel liposomal influenza vaccine (INFLUSOME-VAC) containing hemagglutinin-neuraminidase and IL-2 or GM-CSF induces protective antineuraminidase antibodies cross-reacting with a wide spectrum of influenza A viral strains." Vaccine20(3-4) : 505-15.

17. Baigent SJ and McCauley JW (2001). "Glycosylation of haemagglutinin and stalk-length of neuraminidase combine to regulate the growth of avian influenza viruses in tissue culture." Virus Res79(1-2) : 177-85.

18. Baigent SJ and McCauley JW (2003). "Influenza type A in humans, mammals and birds : determinants of virus virulence, host-range and interspecies transmission." Bioessays25(7) : 657-71.

19. Banks J, Speidel E and Alexander DJ (1998). "Characterisation of an avian influenza A virus isolated from a human  : is an intermediate host necessary for the emergence of pandemic influenza viruses?" Archives of virology143(4) : 781-787.

20. Banks J, Speidel ES, Moore E, Plowright L, Piccirillo A, Capua I, Cordioli P, Fioretti A and Alexander DJ (2001). "Changes in the haemagglutinin and the neuraminidase genes prior to the emergence of highly pathogenic H7N1 avian influenza viruses in Italy." Archives of virology146(5) : 963-973.

21. Bantia S, Arnold CS, Parker CD, Upshaw R and Chand P (2005). "Anti-influenza virus activity of peramivir in mice with single intramuscular injection." Antiviral Res.

22. Beby-Defaux A, Giraudeau G, Bouguermouh S and Agius G (2003). "La grippe humaine : aspects virologiques, épidémiologie et diagnostic virologique. (Influenza : virological aspects, epidemiology and virological diagnosis)." Médecine et maladies infectieuses33(3) : 134-142.

23. Beigel JH, Farrar J, Han AM, Hayden FG, Hyer R, de Jong MD, Lochindarat S, Nguyen TK, Nguyen TH, Tran TH, Nicoll A, Touch S and Yuen KY (2005). "Avian influenza A (H5N1) infection in humans." N Engl J Med 353(13) : 1374-85.

24. Bennink JR and Palmore TN (2004). "The promise of siRNAs for the treatment of influenza." Trends Mol Med10(12) : 571-4.

25. Ben-Yehuda A, Joseph A, Barenholz Y, Zeira E, Even-Chen S, Louria-Hayon I, Babai I, Zakay-Rones Z, Greenbaum E, Galprin I, Gluck R, Zurbriggen R and Kedar E (2003). "Immunogenicity and safety of a novel IL-2-supplemented liposomal influenza vaccine (INFLUSOME-VAC) in nursing-home residents." Vaccine 21(23) : 3169-78.

26. Ben-Yehuda A, Joseph A, Zeira E, Even-Chen S, Louria-Hayon I, Babai I, Zakay-Rones Z, Greenbaum E, Barenholz Y and Kedar E (2003). "Immunogenicity and safety of a novel liposomal influenza subunit vaccine (INFLUSOME-VAC) in young adults." J Med Virol69(4) : 560-7.

27. Boibieux A, Bouhour D, Biron F, Chidiac C and Peyramond D (1998). "La grippe aviaire de Hong Kong. (Avian influenza in Hong Kong)." Médecine et maladies infectieuses28(2) : 193-194.

28. Bridges CB, Katz JM, Seto WH, Chan PKS, Tsang D, Ho W, Mak KH, Lim W, Tam JS, Clarke M, Williams SG, Mounts AW, Bresee JS, Conn LA, Rowe T, Hu-Primmer J, Abernathy RA, Xiuhua LU, Cox NJ and Fukuda K (2000). "Risk of influenza A (H5N1) infection among health care workers exposed to patients with influenza A (H5N1), Hong Kong." The Journal of infectious diseases 181(1) : 344-348.

29. Bridges CB, Lim W, Hu-Primmer J, Sims L, Fukuda K, Mak KH, Rowe T, Thompson WW, Conn L, Lu X, Cox NJ and Katz JM (2002). "Risk of influenza A (H5N1) infection among poultry workers, Hong Kong, 1997-1998." J Infect Dis185(8) : 1005-10.

30. Bright RA, Cho DS, Rowe T and Katz JM (2003). "Mechanisms of pathogenicity of influenza A (H5N1) viruses in mice." Avian Dis47(3 Suppl) : 1131-4.

31. Bright RA, Medina MJ, Xu X, Perez-Oronoz G, Wallis TR, Davis XM, Povinelli L, Cox NJ and Klimov AI (2005). "Incidence of adamantane resistance among influenza A (H3N2) viruses isolated worldwide from 1994 to 2005 : a cause for concern." Lancet366(9492) : 1175-81.

32. Butt KM, Smith GJ, Chen H, Zhang LJ, Leung YH, Xu KM, Lim W, Webster RG, Yuen KY, Peiris JS and Guan Y (2005). "Human Infection with an Avian H9N2 Influenza A Virus in Hong Kong in 2003." J Clin Microbiol43(11) : 5760-7.

33. Cappucci DT, Jr., Johnson DC, Brugh M, Smith TM, Jackson CF, Pearson JE and Senne DA (1985). "Isolation of avian influenza virus (subtype H5N2) from chicken eggs during a natural outbreak." Avian Dis29(4) : 1195-200.

34. Capua I and Alexander DJ (2002). "Avian influenza and human health." Acta tropica83(1) : 1-6.

35. Castrucci MR, Donatelli I, Sidoli L, Barigazzi G, Kawaoka Y and Webster RG(1993). "Genetic reassortment between avian and human influenza A viruses in italian pigs." Virology  : (New York, NY)193(1) : 503-506.

36. Chan PK (2002). "Outbreak of avian influenza A(H5N1) virus infection in Hong Kong in 1997." Clin Infect Dis34 Suppl 2 : S58-64. 37. Chand P, Babu YS, Bantia S, Rowland S, Dehghani A, Kotian PL, Hutchison TL, Ali S, Brouillette W, El-Kattan Y and Lin TH (2004). "Syntheses and neuraminidase inhibitory activity of multisubstituted cyclopentane amide derivatives." J Med Chem47(8) : 1919-29.

38. Chand P, Bantia S, Kotian PL, El-Kattan Y, Lin TH and Babu YS (2005). "Comparison of the anti-influenza virus activity of cyclopentane derivatives with oseltamivir and zanamivir in vivo." Bioorg Med Chem13(12) : 4071-7.

39. Cheng X, Liu J, He J and Shan F (2002). "Virological and serological surveys for H9N2 subtype of influenza A virus in chickens and men in Shenzhen city." Zhonghua Shi Yan He Lin Chuang Bing Du Xue Za Zhi16(4) : 319-21.

40. Cheung CY, Poon LL, Lau AS, Luk W, Lau YL, Shortridge KF, Gordon S, Guan Y and Peiris JS (2002). "Induction of proinflammatory cytokines in human macrophages by influenza A (H5N1) viruses : a mechanism for the unusual severity of human disease?" Lancet360(9348) : 1831-7.

41. Choi YK, Nguyen TD, Ozaki H, Webby RJ, Puthavathana P, Buranathal C, Chaisingh A, Auewarakul P, Hanh NT, Ma SK, Hui PY, Guan Y, Peiris JS and Webster RG (2005). "Studies of H5N1 influenza virus infection of pigs by using viruses isolated in Vietnam and Thailand in 2004." J Virol 79(16) : 10821-5.

42. Chokephaibulkit K, Uiprasertkul M, Puthavathana P, Chearskul P, Auewarakul P, Dowell SF and Vanprapar N (2005). "A child with avian influenza A (H5N1) infection." Pediatr Infect Dis J 24(2) : 162-6.

43. Chotpitayasunondh T, Ungchusak K, Hanshaoworakul W, Chunsuthiwat S, Sawanpanyalert P, Kijphati R, Lochindarat S, Srisan P, Suwan P, Osotthanakorn Y, Anantasetagoon T, Kanjanawasri S, Tanupattarachai S, Weerakul J, Chaiwirattana R, Maneerattanaporn M, Poolsavathitikool R, Chokephaibulkit K, Apisarnthanarak A and Dowell SF (2005). "Human disease from influenza A (H5N1), Thailand, 2004." Emerg Infect Dis 11(2) : 201-9.

44. Claas ECJ, De JJC, Van BR, Rimmelzwaan GF and Osterhaus ADME (1998). "Human influenza virus A/HongKong/156/97 (H5N1) infection." Vaccine16(9-10) : 977-978.

45. Claas ECJ, Van RK and Pensaert M (2000). "Pandemic influenza is a zoonosis, as it requires introduction of avian-like gene segments in the human population." Veterinary microbiology  : (Amsterdam)74(1-2) : 133-139.

46. Coiras MT, Aguilar JC, Galiano M, Carlos S, Gregory V, Lin YP, Hay A and Perez-Brena P (2001). "Rapid molecular analysis of the haemagglutinin gene of human influenza A H3N2 viruses isolated in Spain from 1996 to 2000." Archives of virology146(11) : 2133-2147.

47. Collins RA, Ko L-S, So K-L, Ellis T, Lau L-T and Cheung HOIYUA (2002). "Detection of highly pathogenic and low pathogenic avian influenza subtype H5 (Eurasian lineage) using NASBA." Journal of virological methods103(2) : 213-225.

48. Cooper N, Sutton AJ, Abrams KR, Wailoo A, Turner DA, Nicholson KG and Hansen L (2003). "Effectiveness of neuraminidase inhibitors in treatment and prevention of influenza A and B : systematic review and meta-analyses of randomised controlled trials. Commentary." BMJ. British medical journal  : (International ed.)326(7401) : 1235-1240.

49. Daems R, Del Giudice G and Rappuoli R (2005). "Anticipating crisis : Towards a pandemic flu vaccination strategy through alignment of public health and industrial policy." Vaccine.

50. de Bruijn IA, Nauta J, Cramer WC, Gerez L and Palache AM (2005). "Clinical experience with inactivated, virosomal influenza vaccine." Vaccine23 Suppl 1 : S39-49.

51. de Jong MD, Bach VC, Phan TQ, Vo MH, Tran TT, Nguyen BH, Beld M, Le TP, Truong HK, Nguyen VV, Tran TH, Do QH and Farrar J (2005). "Fatal avian influenza A (H5N1) in a child presenting with diarrhea followed by coma." N Engl J Med352(7) : 686-91. 52. de Jong MD and Hien TT (2006). "Avian influenza A (H5N1)." J Clin Virol35(1) : 2-13.

53. de Jong MD, Tran TT, Truong HK, Vo MH, Smith GJ, Nguyen VC, Bach VC, Phan TQ, Do QH, Guan Y, Peiris JS, Tran TH and Farrar J (2005). "Oseltamivir resistance during treatment of influenza A (H5N1) infection." N Engl J Med 353(25) : 2667-72.

54. Demicheli V, Jefferson T, Rivetti D and Deeks J (2000). "Prevention and early treatment of influenza in healthy adults." Vaccine18(11-12) : 957-1030.

55. Deshpande KL, Naeve CW and Webster RG (1985). "The neuraminidases of the virulent and avirulent A/chicken/Pennsylvania/83 (H5N2) influenza A viruses : sequence and." Virology147(1) : 49-60.

56. Dreitlein WB, Maratos J and Brocavich J (2001). "Zanamivir and oseltamivir  : Two new options for the treatment and prevention of Influenza." Clinical therapeutics23(3) : 327-355.

57. Dutkowski R, Thakrar B, Froehlich E, Suter P, Oo C and Ward P (2003). "Safety and pharmacology of oseltamivir in clinical use." Drug safety26(11) : 787-801.

58. Ellis JS and Zambon MC (2001). "Combined PCR-heteroduplex mobility assay for detection and differentiation of influenza A viruses from different animal species." Journal of clinical microbiology39(11) : 4097-4102.

59. Enserink M (2005). "Avian influenza. 'Pandemic vaccine' appears to protect only at high doses." Science309(5737) : 996.

60. Enserink M and Kaiser J (2004). "Virology. Avian flu finds new mammal hosts." Science305(5689) : 1385.